Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The ZMY-1 system makes hair transplants faster without losing safety or effectiveness.

The updated criteria improve the accuracy of diagnosing lupus.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Lower 2D:4D finger ratios in HS patients suggest prenatal hormone influence on the disease.

A special treatment speeds up chronic wound healing by fixing cell energy issues and reversing aging in cells.

Reliable method detects finasteride in human plasma at low doses.

A wearable patch speeds up healing of chronic wounds by monitoring and treating them.

The 2012 criteria are better for diagnosing atypical lupus cases.

PRP injections help relieve hip pain in most cases.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Electric pulses can effectively activate platelets and release growth factors, offering a better alternative to traditional methods.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

A new method improves protein extraction from hair, helping identify potential biomarkers for fetal growth issues.

A new microneedle system with minoxidil nanoparticles effectively promotes hair regrowth with fewer side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Injectable platelet-rich fibrin has improved healing and regeneration in various medical fields and can be more effective than previous treatments.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

A Taiwanese patient had hair loss and skin bumps without the usual gene mutation, suggesting other genetic factors might be involved.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.